FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Clarke-Pearson

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Daniel L Clarke-Pearson; Elizabeth J Geller
Complications of hysterectomy.
Daniel L Clarke-Pearson
Thromboprophylaxis for gynecologic surgery: why are we stuck in 1975?
Daniel S Higginson; David E Morris; Ellen L Jones; Daniel L Clarke-Pearson; Mahesh Varia
Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Clarke-Pearson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniel L Clarke-Pearson; Elizabeth J Geller
Complications of hysterectomy.
Obstetrics and gynecology 2013;121(3):654-73.
2011: Daniel L Clarke-Pearson
Thromboprophylaxis for gynecologic surgery: why are we stuck in 1975?
Obstetrics and gynecology 2011;118(5):973-5.
2011: Daniel S Higginson; David E Morris; Ellen L Jones; Daniel L Clarke-Pearson; Mahesh Varia
Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology.
Gynecologic oncology 2011;120(3):404-12.
2009: Daniel L Clarke-Pearson
Clinical practice. Screening for ovarian cancer.
The New England journal of medicine 2009;361(2):170-7.
2009: Angeles Alvarez-Secord; Victoria L Bae-Jump; Laura Havrilesky; Brian Calingaert; Daniel L Clarke-Pearson; John Soper; Paola A Gehrig
Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(3):447-54.
2008: A Nicolaides; S Z Goldhaber; G L Maxwell; N Labropoulos; Daniel L Clarke-Pearson; T H Tyllis; M B Griffin
Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery.
International angiology : a journal of the International Union of Angiology 2008;27(6):500-6.
2008: Jay W Carlson; James Kauderer; Joan L Walker; Michael A Gold; David O'Malley; Erin Tuller; Daniel L Clarke-Pearson
A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.
Gynecologic oncology 2008;110(1):76-82.
2008: Martin Martino; L Rajaram; G Larry Maxwell; Daniel L Clarke-Pearson
Combination prophylaxis for thromboembolism prevention among gynecologic oncology patients perioperatively.
Gynecologic oncology 2008;109(3):426-7.
2007: Gary H Lyman; Alok A Khorana; Anna Falanga; Daniel L Clarke-Pearson; Christopher Flowers; Mohammad Jahanzeb; Ajay K Kakkar; Nicole Kuderer; Mark N Levine; Howard Liebman; David S Mendelson; Gary E Raskob; Mark R Somerfield; Paul Thodiyil; David Trent; Charles W Francis
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5490-505.
2007: Angeles Alvarez-Secord; Laura Havrilesky; Victoria L Bae-Jump; Jeanette Chin; Brian Calingaert; Amy Bland; Teresa Rutledge; Andrew Berchuck; Daniel L Clarke-Pearson; Paola A Gehrig
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Gynecologic oncology 2007;107(2):285-91.
2007: David Spriggs; Mark F Brady; Luis Vaccarello; Daniel L Clarke-Pearson; Robert A Burger; Robert S Mannel; John F Boggess; Roger B Lee; Mark Hanly
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4466-71.
2007: Martin A Martino; Eva Williamson; L Rajaram; Johnathan M Lancaster; Mitchel S Hoffman; G Larry Maxwell; Daniel L Clarke-Pearson
Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis.
Gynecologic oncology 2007;106(3):439-45.
2007: Peter G Rose; Shamshad Ali; Edwin Watkins; J Tate Thigpen; Gunter Deppe; Daniel L Clarke-Pearson; Samuel Insalaco
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2804-10.
2007: Laura Havrilesky; Angeles Alvarez Secord; Victoria L Bae-Jump; Tina Ayeni; Brian Calingaert; Daniel L Clarke-Pearson; Andrew Berchuck; Paola A Gehrig
Outcomes in surgical stage I uterine papillary serous carcinoma.
Gynecologic oncology 2007;105(3):677-82.
2007: John Soper; M Spillman; J H Sampson; J P Kirkpatrick; J K Wolf; Daniel L Clarke-Pearson
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Gynecologic oncology 2007;104(3):691-4.
2007: Angeles Alvarez Secord; Laura Havrilesky; Michael E Carney; John Soper; Daniel L Clarke-Pearson; Gustavo Rodriguez; Andrew Berchuck
Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer.
International journal of clinical oncology 2007;12(1):31-6.
2007: Laura Havrilesky; Janiel M Cragun; Brian Calingaert; Angeles Alvarez-Secord; Fidel A Valea; Daniel L Clarke-Pearson; Andrew Berchuck; John Soper
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Gynecologic oncology 2007;104(2):401-5.
2007: John Soper; Angeles Alvarez Secord; Laura Havrilesky; Andrew Berchuck; Daniel L Clarke-Pearson
Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(1):298-303.
2006: G Larry Maxwell; Daniel L Clarke-Pearson
Pulmonary embolism after major abdominal surgery in gynecologic oncology.
Obstetrics and gynecology 2006;108(1):209; author reply 209-11.
2006: Christopher V Lutman; Laura Havrilesky; Janiel M Cragun; Angeles Alvarez Secord; Brian Calingaert; Andrew Berchuck; Daniel L Clarke-Pearson; John Soper
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Gynecologic oncology 2006;102(1):92-7.
2006: Ellen Jones; Angeles Alvarez-Secord; Leonard R Prosnitz; Thaddeus V Samulski; James R Oleson; Andrew Berchuck; Daniel L Clarke-Pearson; John Soper; Mark Dewhirst; Zeljko Vujaskovic
Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2006;22(2):161-72.
2006: Joan L Walker; Deborah K Armstrong; Helen Q Huang; Jeffrey Fowler; Kenneth Webster; Robert A Burger; Daniel L Clarke-Pearson
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
Gynecologic oncology 2006;100(1):27-32.
2005: Laura Havrilesky; Janiel M Cragun; Brian Calingaert; Ingrid Synan; Angeles Alvarez Secord; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Resection of lymph node metastases influences survival in stage IIIC endometrial cancer.
Gynecologic oncology 2005;99(3):689-95.
2005: Benjamin E Greer; Brian N Bundy; Robert F Ozols; Jeffrey M Fowler; Daniel L Clarke-Pearson; Robert A Burger; Robert S Mannel; Koen DeGeest; Ellen M Hartenbach; Rebecca N Baergen; Larry J Copeland
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.
Gynecologic oncology 2005;99(1):71-9.
2005: Angeles Alvarez-Secord; Ellen Jones; Carol A Hahn; William P Petros; D Yu; Laura Havrilesky; John Soper; Andrew Berchuck; Ivan Spasojevic; Daniel L Clarke-Pearson; Leonard R Prosnitz; Mark Dewhirst
Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2005;21(4):333-47.
2005: Janiel M Cragun; Laura Havrilesky; Brian Calingaert; Ingrid Synan; Angeles Alvarez Secord; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3668-75.
2005: John Soper; Laura Havrilesky; Angeles Alvarez Secord; Andrew Berchuck; Daniel L Clarke-Pearson
Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(3):542-8.
2005: John Soper; Angeles Alvarez Secord; Laura Havrilesky; Andrew Berchuck; Daniel L Clarke-Pearson
Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity.
Gynecologic oncology 2005;97(2):596-601.
2004: Peter G Rose; Stacy Nerenstone; Mark F Brady; Daniel L Clarke-Pearson; George Olt; Stephen C Rubin; David H Moore; James M Small
Secondary surgical cytoreduction for advanced ovarian carcinoma.
The New England journal of medicine 2004;351(24):2489-97.
2004: John Soper; Susan A Reisinger; Robert Ashbury; Ellen Jones; Daniel L Clarke-Pearson
Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
Gynecologic oncology 2004;95(1):95-100.
2004: Louis A Dainty; G Larry Maxwell; Daniel L Clarke-Pearson; Evan Myers
Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery.
Gynecologic oncology 2004;93(2):366-73.
2003: Janet S Rader; Daniel L Clarke-Pearson; M Moore; L Carson; R Holloway; M-S Kao; I Wiznitzer; E C Douglass
A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer.
Gynecologic oncology 2003;91(2):318-25.
2003: Ted M Roth; Angeles Alvarez Secord; Laura Havrilesky; Ellen Jones; Daniel L Clarke-Pearson
High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease.
Gynecologic oncology 2003;91(1):258-60.
2003: Robert F Ozols; Brian N Bundy; Benjamin E Greer; Jeffrey M Fowler; Daniel L Clarke-Pearson; Robert A Burger; Robert S Mannel; Koen DeGeest; Ellen M Hartenbach; Rebecca Baergen
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3194-200.
2003: Laura Havrilesky; Bercedis L Peterson; Damla K Dryden; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Predictors of clinical outcomes in the laparoscopic management of adnexal masses.
Obstetrics and gynecology 2003;102(2):243-51.
2003: Mahesh Varia; Frederick B Stehman; Brian N Bundy; Jo Ann Benda; Daniel L Clarke-Pearson; Ronald D Alvarez; Harry J Long
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2849-55.
2003: Ellen Jones; Thaddeus V Samulski; Mark Dewhirst; Angeles Alvarez-Secord; Andrew Berchuck; Daniel L Clarke-Pearson; Laura Havrilesky; John Soper; Leonard R Prosnitz
A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.
Cancer 2003;98(2):277-82.
2003: Laura Havrilesky; Terence Z Wong; Angeles Alvarez Secord; Andrew Berchuck; Daniel L Clarke-Pearson; Ellen Jones
The role of PET scanning in the detection of recurrent cervical cancer.
Gynecologic oncology 2003;90(1):186-90.
2003: Jeffrey D Bloss; Mark F Brady; Shu Yuan Liao; Thomas F Rocereto; Edward E Partridge; Daniel L Clarke-Pearson
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study.
Gynecologic oncology 2003;89(1):148-54.
2003: Michael A Bookman; Kathleen M Darcy; Daniel L Clarke-Pearson; Richard A Boothby; Ira R Horowitz
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):283-90.
2003: Daniel L Clarke-Pearson; Richard K Dodge; Ingrid Synan; R Craig McClelland; G Larry Maxwell
Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression.
Obstetrics and gynecology 2003;101(1):157-63.
2003: Laura Havrilesky; Angeles A Alvarez; Robyn A Sayer; Johnathan M Lancaster; John Soper; Andrew Berchuck; Daniel L Clarke-Pearson; Gustavo Rodriguez; Michael E Carney
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.
Gynecologic oncology 2003;88(1):51-7.
2002: G Larry Maxwell; Ingrid Synan; Risa P Hayes; Daniel L Clarke-Pearson
Preference and compliance in postoperative thromboembolism prophylaxis among gynecologic oncology patients.
Obstetrics and gynecology 2002;100(3):451-5.
2002: M Gore; Amit Oza; G Rustin; John Malfetano; H Calvert; Daniel L Clarke-Pearson; J Carmichael; G Ross; RA Beckman; Scott Z Fields
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(1):57-63.
2001: G Larry Maxwell; Ingrid Synan; Richard K Dodge; B Carroll; Daniel L Clarke-Pearson
Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial.
Obstetrics and gynecology 2001;98(6):989-95.
2001: Daniel L Clarke-Pearson; Linda Van Le; T Iveson; CW Whitney; P Hanjani; Gunnar Kristensen; John Malfetano; RA Beckman; GA Ross; SR Lane; Mark DeWitte; Scott Z Fields
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3967-75.
2000: Frank D Cirisano; Stanley J Robboy; Richard K Dodge; Rex C Bentley; HR Krigman; Ingrid Synan; John Soper; Daniel L Clarke-Pearson
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Gynecologic oncology 2000;77(1):55-65.
2000: G Larry Maxwell; Evan Myers; Daniel L Clarke-Pearson
Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery.
Obstetrics and gynecology 2000;95(2):206-14.
1999: Frank D Cirisano; Stanley J Robboy; Richard K Dodge; Rex C Bentley; HR Krigman; Ingrid Synan; John Soper; Daniel L Clarke-Pearson
Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Gynecologic oncology 1999;74(3):385-94.
1999: H Ashih; Tara Gustilo-Ashby; Evan Myers; J Andrews; Daniel L Clarke-Pearson; D Berry; Andrew Berchuck
Cost-effectiveness of treatment of early stage endometrial cancer.
Gynecologic oncology 1999;74(2):208-16.
1999: CW Whitney; William T Sause; Brian N Bundy; John Malfetano; Edward V Hannigan; Wesley C Fowler; Daniel L Clarke-Pearson; S Y Liao
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1339-48.
1999: Peter G Rose; Brian N Bundy; E B Watkins; J Tate Thigpen; Gunter Deppe; M A Maiman; Daniel L Clarke-Pearson; S Insalaco
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
The New England journal of medicine 1999;340(15):1144-53.
1998: M P Boente; Andrew Berchuck; Regina S Whitaker; A Kalén; FJ Xu; Daniel L Clarke-Pearson; RM Bell; Robert C Bast
Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell lines.
Gynecologic oncology 1998;70(1):49-55.
1997: J A Roberts; E L Jenison; K Kim; Daniel L Clarke-Pearson; A Langleben
A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
Gynecologic oncology 1997;67(2):172-7.
1997: S L Clifford; C P Kaminetsky; Frank D Cirisano; Richard K Dodge; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer.
American journal of obstetrics and gynecology 1997;176(6):S229-32.
1997: William P McGuire; W J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; Katherine Y Look; Daniel L Clarke-Pearson; M Davidson
Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study.
Seminars in oncology 1997;24(1 Suppl 2):S2-13-S2-16.
1997: George A Omura; John A Blessing; Luis Vaccarello; M L Berman; Daniel L Clarke-Pearson; David G Mutch; B Anderson
Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):165-71.
1996: D S Alberts; PY Liu; E V Hannigan; R O'Toole; S D Williams; J A Young; E W Franklin; Daniel L Clarke-Pearson; V K Malviya; B DuBeshter
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
The New England journal of medicine 1996;335(26):1950-5.
1996: Katherine Y Look; Virginia L Brunetto; Daniel L Clarke-Pearson; H E Averette; F J Major; R D Alvarez; Howard D Homesley; Richard J Zaino
An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Gynecologic oncology 1996;63(3):304-11.
1996: Matthew F Kohler; P Carney; R Dodge; John Soper; Daniel L Clarke-Pearson; Jeffrey R Marks; Andrew Berchuck
p53 overexpression in advanced-stage endometrial adenocarcinoma.
American journal of obstetrics and gynecology 1996;175(5):1246-52.
1996: William P McGuire; William J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; K Y Look; Daniel L Clarke-Pearson; M Davidson
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
Seminars in oncology 1996;23(5 Suppl 12):40-7.
1996: L Stewart Massad; P Bitterman; Daniel L Clarke-Pearson
Metastatic clear cell eccrine hidradenocarcinoma of the vulva: survival after primary surgical resection.
Gynecologic oncology 1996;61(2):287-90.
1996: G Olt; John Soper; Sundaram Ramakrishnan; F Xu; Andrew Berchuck; Daniel L Clarke-Pearson; R Dodge; Robert C Bast
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer.
American journal of obstetrics and gynecology 1996;174(4):1316-9.
1996: Frederick B Stehman; Brian N Bundy; H Ball; Daniel L Clarke-Pearson
Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study.
American journal of obstetrics and gynecology 1996;174(4):1128-32; discussion 1132-3.
1996: William P McGuire; William J Hoskins; Mark F Brady; P R Kucera; Edward E Partridge; K Y Look; Daniel L Clarke-Pearson; M Davidson
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
The New England journal of medicine 1996;334(1):1-6.
1995: David H Moore; Fidel A Valea; Leslie Walton; John Soper; Daniel L Clarke-Pearson; Wesley C Fowler
A phase I study of intraperitoneal interferon-alpha 2b and intravenous cis-platinum plus cyclophosphamide chemotherapy in patients with untreated stage III epithelial ovarian cancer: a Gynecologic Oncology Group pilot study.
Gynecologic oncology 1995;59(2):267-72.
1995: A C Evans; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck; Gustavo Rodriguez; C B Hammond
Gestational trophoblastic disease metastatic to the central nervous system.
Gynecologic oncology 1995;59(2):226-30.
1995: J Rebecca Liu; M Conaway; Gustavo Rodriguez; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck
Relationship between race and interval to treatment in endometrial cancer.
Obstetrics and gynecology 1995;86(4 Pt 1):486-90.
1995: Andrew Berchuck; C Anspach; A C Evans; John Soper; Gustavo Rodriguez; Richard K Dodge; Stanley J Robboy; Daniel L Clarke-Pearson
Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma.
Gynecologic oncology 1995;59(1):20-4.
1995: J A Hurteau; Gustavo Rodriguez; HH Kay; R C Bentley; Daniel L Clarke-Pearson
Villoglandular adenocarcinoma of the cervix: a case report.
Obstetrics and gynecology 1995;85(5 Pt 2):906-8.
1995: John Soper; A C Evans; Gustavo Rodriguez; Andrew Berchuck; Daniel L Clarke-Pearson; C B Hammond
Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.
Gynecologic oncology 1995;56(3):421-4.
1995: John Soper; Gustavo Rodriguez; Andrew Berchuck; Daniel L Clarke-Pearson
Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications.
Gynecologic oncology 1995;56(2):271-5.
1994: John Soper; A C Evans; M R Conaway; Daniel L Clarke-Pearson; Andrew Berchuck; C B Hammond
Evaluation of prognostic factors and staging in gestational trophoblastic tumor.
Obstetrics and gynecology 1994;84(6):969-73.
1994: Gustavo Rodriguez; Claude L Hughes; John Soper; Andrew Berchuck; Daniel L Clarke-Pearson; C B Hammond
Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia.
Obstetrics and gynecology 1994;84(5):794-7.
1994: John Soper; Daniel L Clarke-Pearson; Andrew Berchuck; Gustavo Rodriguez; C B Hammond
5-day methotrexate for women with metastatic gestational trophoblastic disease.
Gynecologic oncology 1994;54(1):76-9.
1994: Daniel L Clarke-Pearson; Matthew F Kohler; J A Hurteau; A Elbendary
Surgery for advanced ovarian cancer.
Clinical obstetrics and gynecology 1994;37(2):439-60.
1994: A S Lukes; Matthew F Kohler; C F Pieper; B J Kerns; R Bentley; Gustavo Rodriguez; John Soper; Daniel L Clarke-Pearson; Robert C Bast; Andrew Berchuck
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.
Cancer 1994;73(9):2380-5.
1994: FJ Xu; YH Yu; L Daly; L Anselmino; G M Hass; Andrew Berchuck; Gustavo Rodriguez; John Soper; Daniel L Clarke-Pearson; D Hollis
OVX1 as a marker for early stage endometrial carcinoma.
Cancer 1994;73(7):1855-8.
1994: Gustavo Rodriguez; Daniel L Clarke-Pearson; John Soper; Andrew Berchuck; I Synan; Richard K Dodge
The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
Obstetrics and gynecology 1994;83(3):445-8.
1994: Evan Myers; Daniel L Clarke-Pearson; G J Olt; John Soper; Andrew Berchuck
Preoperative coagulation testing on a gynecologic oncology service.
Obstetrics and gynecology 1994;83(3):438-44.
1994: S Ben-Haim; D Kahn; George J Weiner; Mark T Madsen; A D Waxman; C M Williams; Daniel L Clarke-Pearson; R E Coleman; R T Maguire
The safety and pharmacokinetics in adult subjects of an intravenously administered 99mTc-labeled 17 amino acid peptide (CYT-379).
Nuclear medicine and biology 1994;21(2):131-42.
1994: Daniel L Clarke-Pearson
The reassessment of ovarian cancer in complete clinical remission: what are our goals?
Gynecologic oncology 1994;52(2):151-3.
1994: Andrew Berchuck; Matthew F Kohler; M P Hopkins; P A Humphrey; Stanley J Robboy; Gustavo Rodriguez; John Soper; Daniel L Clarke-Pearson; Robert C Bast
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.
Gynecologic oncology 1994;52(2):232-6.
1994: John Soper; A C Evans; Daniel L Clarke-Pearson; Andrew Berchuck; Gustavo Rodriguez; C B Hammond
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Obstetrics and gynecology 1994;83(1):113-7.
1993: K A Leopold; J R Oleson; Daniel L Clarke-Pearson; John Soper; Andrew Berchuck; Thaddeus V Samulski; Rodney L Page; J Blivin; J K Tomberlin; Mark Dewhirst
Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma.
International journal of radiation oncology, biology, physics 1993;27(5):1245-51.
1993: R F Asbury; John A Blessing; K Y Look; Daniel L Clarke-Pearson; H D Homesley
A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancer.
American journal of clinical oncology 1993;16(6):529-31.
1993: A P Soisson; G Olt; John Soper; Andrew Berchuck; Gustavo Rodriguez; Daniel L Clarke-Pearson
Prevention of superficial wound separation with subcutaneous retention sutures.
Gynecologic oncology 1993;51(3):330-4.
1993: Robert P Woolas; FJ Xu; Ian J Jacobs; YH Yu; L Daly; Andrew Berchuck; John Soper; Daniel L Clarke-Pearson; David H Oram; Robert C Bast
Elevation of multiple serum markers in patients with stage I ovarian cancer.
Journal of the National Cancer Institute 1993;85(21):1748-51.
1993: Matthew F Kohler; Jeffrey R Marks; Roger W Wiseman; Ian J Jacobs; Andrew M Davidoff; Daniel L Clarke-Pearson; John Soper; Robert C Bast; Andrew Berchuck
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
Journal of the National Cancer Institute 1993;85(18):1513-9.
1993: Matthew F Kohler; H Nishii; P A Humphrey; H Saski; J Marks; Robert C Bast; Daniel L Clarke-Pearson; J Boyd; Andrew Berchuck
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.
American journal of obstetrics and gynecology 1993;169(3):690-4.
1993: FJ Xu; YH Yu; L Daly; Karen DeSombre; L Anselmino; G M Hass; Andrew Berchuck; John Soper; Daniel L Clarke-Pearson; C Boyer
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1506-10.
1993: Daniel L Clarke-Pearson; I S Synan; R Dodge; John Soper; Andrew Berchuck; R Edward Coleman
A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery.
American journal of obstetrics and gynecology 1993;168(4):1146-53; discussion 1153-4.
1993: Daniel L Clarke-Pearson
Prevention of venous thromboembolism in gynecologic surgery patients.
Current opinion in obstetrics & gynecology 1993;5(1):73-9.
1992: A P Soisson; John Soper; Andrew Berchuck; R Dodge; Daniel L Clarke-Pearson
Radical hysterectomy in obese women.
Obstetrics and gynecology 1992;80(6):940-3.
1992: MP Boente; Andrew Berchuck; Gustavo Rodriguez; A Davidoff; R Whitaker; FJ Xu; J Marks; Daniel L Clarke-Pearson; Robert C Bast
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.
American journal of obstetrics and gynecology 1992;167(6):1877-82.
1992: John Soper; P Johnson; V Johnson; Andrew Berchuck; Daniel L Clarke-Pearson
Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma.
Obstetrics and gynecology 1992;80(6):949-53.
1992: Gustavo Rodriguez; John Soper; Andrew Berchuck; J Oleson; Richard K Dodge; Gustavo S Montana; Daniel L Clarke-Pearson
Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1553-60.
1992: A N Nicolaides; Juan I Arcelus; G Belcaro; D Bergqvist; L C Borris; H R Buller; J A Caprini; D Christopoulos; Daniel L Clarke-Pearson; D Clement
Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK.
International angiology : a journal of the International Union of Angiology 1992;11(3):151-9.
1992: John Soper; Andrew Berchuck; R Dodge; Daniel L Clarke-Pearson
Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
Obstetrics and gynecology 1992;79(6):993-7.
1992: Matthew F Kohler; Andrew Berchuck; Andrew M Davidoff; P A Humphrey; Richard K Dodge; J Dirk Iglehart; John Soper; Daniel L Clarke-Pearson; Robert C Bast; Jeffrey R Marks
Overexpression and mutation of p53 in endometrial carcinoma.
Cancer research 1992;52(6):1622-7.
1992: Matthew F Kohler; Daniel L Clarke-Pearson
Fine-needle aspiration biopsy in gynecologic oncology.
Clinical obstetrics and gynecology 1992;35(1):73-88.
1992: Andrew Berchuck; Gustavo Rodriguez; G Olt; R Whitaker; MP Boente; B A Arrick; Daniel L Clarke-Pearson; Robert C Bast
Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta.
American journal of obstetrics and gynecology 1992;166(2):676-84.
1992: Andrew Berchuck; M P Boente; B J Kerns; R B Kinney; John Soper; Daniel L Clarke-Pearson; Robert C Bast; S S Bacus
Ploidy analysis of epithelial ovarian cancers using image cytometry.
Gynecologic oncology 1992;44(1):61-5.
1991: L S Massad; V J Hunter; C A Szpak; Daniel L Clarke-Pearson; William T Creasman
Epithelial ovarian tumors of low malignant potential.
Obstetrics and gynecology 1991;78(6):1027-32.
1991: FJ Xu; Sundaram Ramakrishnan; L Daly; John Soper; Andrew Berchuck; Daniel L Clarke-Pearson; Robert C Bast
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer.
American journal of obstetrics and gynecology 1991;165(5 Pt 1):1356-62.
1991: Matthew F Kohler; John Soper; J A Tucker; Daniel L Clarke-Pearson
Isolated incisional metastases after intraperitoneal radioactive chromic phosphate therapy for ovarian carcinoma.
Cancer 1991;68(6):1380-3.
1991: John Soper; Andrew Berchuck; Daniel L Clarke-Pearson
Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
Cancer 1991;68(4):725-9.
1991: Jeffrey R Marks; Andrew M Davidoff; B J Kerns; P A Humphrey; J C Pence; Richard K Dodge; Daniel L Clarke-Pearson; J Dirk Iglehart; Robert C Bast; Andrew Berchuck
Overexpression and mutation of p53 in epithelial ovarian cancer.
Cancer research 1991;51(11):2979-84.
1991: John Soper; Grace M Couchman; Andrew Berchuck; Daniel L Clarke-Pearson
The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma.
Gynecologic oncology 1991;41(3):239-44.
1991: Charles H Livengood; John Soper; Daniel L Clarke-Pearson; WA Addison
Necrotizing fasciitis in irradiated tissue from diabetic women. A report of two cases.
The Journal of reproductive medicine 1991;36(6):455-8.
1991: W Cliby; A P Soisson; Andrew Berchuck; Daniel L Clarke-Pearson
Stage I small cell carcinoma of the vulva treated with vulvectomy, lymphadenectomy, and adjuvant chemotherapy.
Cancer 1991;67(9):2415-7.
1991: Gustavo Rodriguez; Andrew Berchuck; Regina S Whitaker; D Schlossman; Daniel L Clarke-Pearson; Robert C Bast
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor.
American journal of obstetrics and gynecology 1991;164(3):745-50.
1991: R E Slayton; John A Blessing; Daniel L Clarke-Pearson
A phase II trial of diaziquone (AZQ) in mixed mesodermal sarcomas of the uterus. A Gynecologic Oncology Group study.
Investigational new drugs 1991;9(1):93-4.
1991: Andrew Berchuck; Gustavo Rodriguez; A Kamel; R K Dodge; John Soper; Daniel L Clarke-Pearson; Robert C Bast
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.
American journal of obstetrics and gynecology 1991;164(2):669-74.
1991: John Soper; Andrew Berchuck; Daniel L Clarke-Pearson
The clinical significance of blood transfusion at the time of radical hysterectomy.
Obstetrics and gynecology 1991;77(1):165-6.
1991: Andrew Berchuck; Gustavo Rodriguez; R B Kinney; John Soper; R K Dodge; Daniel L Clarke-Pearson; Robert C Bast
Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease.
American journal of obstetrics and gynecology 1991;164(1 Pt 1):15-21.
1990: John Soper; Andrew Berchuck; G J Olt; A P Soisson; Daniel L Clarke-Pearson; Robert C Bast
Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma.
American journal of obstetrics and gynecology 1990;163(4 Pt 1):1204-9.
1990: Matthew F Kohler; Andrew Berchuck; M E Baker; C A Szpak; John Soper; Daniel L Clarke-Pearson
Computed tomography-guided fine-needle aspiration of retroperitoneal lymph nodes in gynecologic oncology.
Obstetrics and gynecology 1990;76(4):612-6.
1990: V J Hunter; L Daly; M Helms; John Soper; Andrew Berchuck; Daniel L Clarke-Pearson; Robert C Bast
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction.
American journal of obstetrics and gynecology 1990;163(4 Pt 1):1164-7.
1990: Gunilla C Bentel; J R Oleson; Daniel L Clarke-Pearson; John Soper; Gustavo S Montana
Transperineal templates for brachytherapy treatment of pelvic malignancies--a comparison of standard and customized templates.
International journal of radiation oncology, biology, physics 1990;19(3):751-8.
1990: D G Mutch; John Soper; C J Babcock; Daniel L Clarke-Pearson; C B Hammond
Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center.
Cancer 1990;66(5):978-82.
1990: E J Shpall; Daniel L Clarke-Pearson; John Soper; Andrew Berchuck; R B Jones; Robert C Bast; Maureen Ross; Y Lidor; K Vanacek; T Tyler
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.
Gynecologic oncology 1990;38(3):386-91.
1990: Andrew Berchuck; Gustavo Rodriguez; A Kamel; John Soper; Daniel L Clarke-Pearson; Robert C Bast
Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina.
Obstetrics and gynecology 1990;76(3 Pt 1):381-7.
1990: A P Soisson; G Geszler; John Soper; Andrew Berchuck; Daniel L Clarke-Pearson
A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy.
Obstetrics and gynecology 1990;76(1):106-9.
1990: Andrew Berchuck; A Kamel; R Whitaker; B Kerns; G Olt; R Kinney; John Soper; Richard K Dodge; Daniel L Clarke-Pearson; P Marks
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
Cancer research 1990;50(13):4087-91.
1990: A P Soisson; John Soper; Daniel L Clarke-Pearson; Andrew Berchuck; Gustavo S Montana; William T Creasman
Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer.
Gynecologic oncology 1990;37(3):390-5.
1990: Andrew Berchuck; G J Olt; A P Soisson; A Kamel; John Soper; CM Boyer; Daniel L Clarke-Pearson; D S Leslie; Robert C Bast
Heterogeneity of antigen expression in advanced epithelial ovarian cancer.
American journal of obstetrics and gynecology 1990;162(4):883-8.
1990: G J Olt; C Greenberg; I Synan; R Edward Coleman; Daniel L Clarke-Pearson
Preoperative assessment of fragment D-dimer as a predictor of postoperative venous thrombosis.
American journal of obstetrics and gynecology 1990;162(3):772-5.
1990: M E King; L M DiGiovanni; J F Yung; Daniel L Clarke-Pearson
Immature teratoma of the ovary grade 3, with karyotype analysis.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1990;9(2):178-84.
1989: John Soper; D Larson; V J Hunter; Andrew Berchuck; Daniel L Clarke-Pearson
Short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery.
Obstetrics and gynecology 1989;74(5):823-7.
1989: A P Soisson; Andrew Berchuck; Bruce A Lessey; John Soper; Daniel L Clarke-Pearson; K S McCarty; Robert C Bast
Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levels.
American journal of obstetrics and gynecology 1989;161(5):1258-63.
1989: Andrew Berchuck; A P Soisson; G J Olt; John Soper; Daniel L Clarke-Pearson; Robert C Bast; K S McCarty
Epidermal growth factor receptor expression in normal and malignant endometrium.
American journal of obstetrics and gynecology 1989;161(5):1247-52.
1989: Andrew Berchuck; A P Soisson; John Soper; Daniel L Clarke-Pearson; Robert C Bast; K S McCarty
Reactivity of epidermal growth factor receptor monoclonal antibodies with human uterine tissues.
Archives of pathology & laboratory medicine 1989;113(10):1155-8.
1989: John Soper; Andrew Berchuck; William T Creasman; Daniel L Clarke-Pearson
Pelvic exenteration: factors associated with major surgical morbidity.
Gynecologic oncology 1989;35(1):93-8.
1989: Andrew Berchuck; A P Soisson; Daniel L Clarke-Pearson; John Soper; CM Boyer; R B Kinney; K S McCarty; Robert C Bast
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
Cancer research 1989;49(8):2091-5.
1989: Daniel L Clarke-Pearson; G Olt
Thromboembolism in patients with Gyn tumors: risk factors, natural history, and prophylaxis.
Oncology (Williston Park, N.Y.) 1989;3(1):39-45; discussion 45, 48.
1988: John Soper; D G Mutch; N Chin; Daniel L Clarke-Pearson; C B Hammond
Renal metastases of gestational trophoblastic disease: a report of eight cases.
Obstetrics and gynecology 1988;72(5):796-8.
1988: E R DeLong; D M DeLong; Daniel L Clarke-Pearson
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
Biometrics 1988;44(3):837-45.
1988: John Soper; T M Blaszczyk; E Oke; Daniel L Clarke-Pearson; William T Creasman
Percutaneous nephrostomy in gynecologic oncology patients.
American journal of obstetrics and gynecology 1988;158(5):1126-31.
1988: John Soper; Daniel L Clarke-Pearson; William T Creasman
Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies.
Gynecologic oncology 1988;29(3):283-9.
1988: John Soper; Daniel L Clarke-Pearson; C B Hammond
Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
Obstetrics and gynecology 1988;71(3 Pt 1):338-43.
1988: Daniel L Clarke-Pearson; E R DeLong; N Chin; R Rice; William T Creasman
Intestinal obstruction in patients with ovarian cancer. Variables associated with surgical complications and survival.
Archives of surgery (Chicago, Ill. : 1960) 1988;123(1):42-5.
1988: Daniel L Clarke-Pearson; John Soper; William T Creasman
Absorbable synthetic mesh (polyglactin 910) for the formation of a pelvic "lid" after radical pelvic resection.
American journal of obstetrics and gynecology 1988;158(1):158-61.
1987: C R Beckmann; Daniel L Clarke-Pearson; R Evenhouse
A reusable plastic training model for teaching Papanicolaou smear technique.
American journal of obstetrics and gynecology 1987;157(2):259-60.
1987: John Soper; R H Wilkinson; L C Bandy; Daniel L Clarke-Pearson; William T Creasman
Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging.
American journal of obstetrics and gynecology 1987;156(5):1153-8.
1987: Daniel L Clarke-Pearson; E R DeLong; I S Synan; R E Coleman; William T Creasman
Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model.
Obstetrics and gynecology 1987;69(2):146-50.
1987: L C Bandy; Daniel L Clarke-Pearson; John Soper; D G Mutch; J MacMillan; William T Creasman
Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation.
Gynecologic oncology 1987;26(2):160-8.
1987: Daniel L Clarke-Pearson; N O Chin; E R DeLong; R Rice; William T Creasman
Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival.
Gynecologic oncology 1987;26(1):11-8.
1986: William T Creasman; John Soper; Daniel L Clarke-Pearson
Radical hysterectomy as therapy for early carcinoma of the cervix.
American journal of obstetrics and gynecology 1986;155(5):964-9.
1986: D G Mutch; John Soper; M E Baker; L C Bandy; E B Cox; Daniel L Clarke-Pearson; C B Hammond
Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease.
Obstetrics and gynecology 1986;68(3):348-52.
1986: William T Creasman; D Henderson; W Hinshaw; Daniel L Clarke-Pearson
Estrogen replacement therapy in the patient treated for endometrial cancer.
Obstetrics and gynecology 1986;67(3):326-30.
1986: Daniel L Clarke-Pearson; L C Bandy; M Dudzinski; D Heaston; William T Creasman
Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings.
JAMA : the journal of the American Medical Association 1986;255(5):627-30.
1986: K A Doman; M Gore; K E Miller; S J Soong; Daniel L Clarke-Pearson; S V Pizzo
Defective release of vascular plasminogen activator in patients with gynecologic malignancies.
Gynecologic oncology 1986;23(2):141-8.
1986: J G Puleo; Daniel L Clarke-Pearson; E B Smith; D E Barnard; William T Creasman
Superior vena cava syndrome associated with gynecologic malignancy.
Gynecologic oncology 1986;23(1):59-64.
1985: John Soper; William T Creasman; Daniel L Clarke-Pearson; D C Sullivan; F Vergadoro; W W Johnston
Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
American journal of obstetrics and gynecology 1985;153(2):191-6.
1985: William T Creasman; B F Fetter; Daniel L Clarke-Pearson; L Kaufmann; R T Parker
Management of stage IA carcinoma of the cervix.
American journal of obstetrics and gynecology 1985;153(2):164-72.
1985: Daniel L Clarke-Pearson; William T Creasman
A clinical evaluation of absorbable polydioxanone ligating clips in abdominal and pelvic operations.
Surgery, gynecology & obstetrics 1985;161(3):250-2.
1985: Daniel L Clarke-Pearson; R E Coleman; R Siegel; I S Synan; N Petry
Indium 111 platelet imaging for the detection of deep venous thrombosis and pulmonary embolism in patients without symptoms after surgery.
Surgery 1985;98(1):98-104.
1985: J F Barter; E B Smith; C A Szpak; W Hinshaw; Daniel L Clarke-Pearson; William T Creasman
Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases.
Gynecologic oncology 1985;21(2):220-7.
1985: William T Creasman; John Soper; K S McCarty; K S McCarty; W Hinshaw; Daniel L Clarke-Pearson
Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
American journal of obstetrics and gynecology 1985;151(7):922-32.
1985: L C Bandy; Daniel L Clarke-Pearson; C B Hammond
Pseudoobstruction of the colon complicating choriocarcinoma.
Gynecologic oncology 1985;20(3):402-7.
1985: R T Zern; Daniel L Clarke-Pearson
Pneumatosis intestinalis associated with enteral feeding by catheter jejunostomy.
Obstetrics and gynecology 1985;65(3 Suppl):81S-83S.
1985: L C Bandy; Daniel L Clarke-Pearson; P M Silverman; William T Creasman
Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervix.
Obstetrics and gynecology 1985;65(1):73-6.
1985: K J Fortier; Daniel L Clarke-Pearson; William T Creasman; W W Johnston
Fine-needle aspiration in gynecology: evaluation of extrapelvic lesions in patients with gynecologic malignancy.
Obstetrics and gynecology 1985;65(1):67-72.
1984: E B Smith; Daniel L Clarke-Pearson; William T Creasman
A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies.
American journal of obstetrics and gynecology 1984;150(8):927-31.
1984: Daniel L Clarke-Pearson; E R DeLong; I S Synan; William T Creasman
Complications of low-dose heparin prophylaxis in gynecologic oncology surgery.
Obstetrics and gynecology 1984;64(5):689-94.
1984: John Soper; K S McCarty; William T Creasman; Daniel L Clarke-Pearson; K S McCarty
Induction of cytoplasmic progesterone receptor in human endometrial carcinoma transplanted into nude mice.
American journal of obstetrics and gynecology 1984;150(4):437-9.
1984: John Soper; K S McCarty; W Hinshaw; William T Creasman; K S McCarty; Daniel L Clarke-Pearson
Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas.
American journal of obstetrics and gynecology 1984;150(4):342-8.
1984: L C Bandy; Daniel L Clarke-Pearson; C B Hammond
Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life.
Obstetrics and gynecology 1984;64(3):395-9.
1984: M Gore; K E Miller; S J Soong; Daniel L Clarke-Pearson; S V Pizzo
Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies.
American journal of obstetrics and gynecology 1984;149(8):830-4.
1984: Daniel L Clarke-Pearson; R E Coleman; N Petry; I S Synan; William T Creasman
Postoperative pelvic vein thrombosis and pulmonary embolism detected by indium 111-labeled platelet imaging: a case report.
American journal of obstetrics and gynecology 1984;149(7):796-8.
1984: Daniel L Clarke-Pearson; William T Creasman; R E Coleman; I S Synan; W M Hinshaw
Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial.
Gynecologic oncology 1984;18(2):226-32.
1984: Daniel L Clarke-Pearson; I S Synan; R E Colemen; W Hinshaw; William T Creasman
The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients.
American journal of obstetrics and gynecology 1984;148(8):1051-4.
1984: L C Bandy; Daniel L Clarke-Pearson; William T Creasman
Vitamin-B12 deficiency following therapy in gynecologic oncology.
Gynecologic oncology 1984;17(3):370-4.
1984: William T Creasman; W M Hinshaw; Daniel L Clarke-Pearson
Cryosurgery in the management of cervical intraepithelial neoplasia.
Obstetrics and gynecology 1984;63(2):145-9.
1984: Daniel L Clarke-Pearson; I S Synan; W M Hinshaw; R E Coleman; William T Creasman
Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy.
Obstetrics and gynecology 1984;63(1):92-8.
1984: C B Hammond; Daniel L Clarke-Pearson; John Soper
Management of patients with gestational trophoblastic neoplasia: experience of the Southeastern Regional Center.
Advances in experimental medicine and biology 1984;176():369-81.
1983: Daniel L Clarke-Pearson; I S Synan; William T Creasman
Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy.
American journal of obstetrics and gynecology 1983;147(4):369-75.
1983: William T Creasman; Daniel L Clarke-Pearson
Immunotherapy of ovarian cancer.
Clinics in obstetrics and gynaecology 1983;10(2):297-306.
1983: Daniel L Clarke-Pearson; William T Creasman; M Ralston; R E Coleman
Indium-labelled platelet imaging of postoperative pelvic vein thrombi.
Obstetrics and gynecology 1983;62(1):109-16.
1983: Daniel L Clarke-Pearson; R E Coleman; I S Synan; W Hinshaw; William T Creasman
Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin.
American journal of obstetrics and gynecology 1983;145(5):606-13.
1983: Daniel L Clarke-Pearson; F R Jelovsek; William T Creasman
Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis.
Obstetrics and gynecology 1983;61(1):87-94.
1982: Daniel L Clarke-Pearson; I S Synan; William T Creasman
Significant venous thromboembolism caused by pelvic lymphocysts: diagnosis and management.
Gynecologic oncology 1982;13(1):136-43.
1981: William T Creasman; Daniel L Clarke-Pearson; J C Weed
Results of outpatient therapy of cervical intraepithelial neoplasia.
Gynecologic oncology 1981;12(2 Pt 2):S306-16.
1981: William T Creasman; Daniel L Clarke-Pearson; C Ashe; J C Weed
The abnormal Pap smear--what to do next?
Cancer 1981;48(2 Suppl):515-22.
1981: Daniel L Clarke-Pearson; William T Creasman
Diagnosis of deep venous thrombosis in obstetrics and gynecology by impedance phlebography.
Obstetrics and gynecology 1981;58(1):52-7.
1981: Daniel L Clarke-Pearson; F R Jelovsek
Alterations of occlusive cuff impedance plethysmography results in the obstetric patient.
Surgery 1981;89(5):594-8.
1980: Daniel L Clarke-Pearson
Low-dose heparin in prevention of venous thromboembolism.
American journal of obstetrics and gynecology 1980;138(4):471-2.
1980: Daniel L Clarke-Pearson
Prevention of recurrent venous thrombosis: warfarin versus heparin.
The New England journal of medicine 1980;302(13):752-3.